In last trading session, Inovio Pharmaceuticals Inc (NASDAQ:INO) saw 0.7 million shares changing hands with its beta currently measuring 1.34. Company’s recent per share price level of $2.05 trading at $0.1 or 5.13% at ring of the bell on the day assigns it a market valuation of $75.19M. That closing price of INO’s stock is at a discount of -555.61% from its 52-week high price of $13.44 and is indicating a premium of 30.73% from its 52-week low price of $1.42. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.5 million shares which gives us an average trading volume of 655.57K if we extend that period to 3-months.
For Inovio Pharmaceuticals Inc (INO), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 2.00. Splitting up the data highlights that, out of 3 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 1 suggested the stock as a Hold whereas 2 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
Inovio Pharmaceuticals Inc (NASDAQ:INO) trade information
Upright in the green during last session for gaining 5.13%, in the last five days INO remained trading in the green while hitting it’s week-highest on Friday, 05/16/25 when the stock touched $2.05 price level, adding 0.49% to its value on the day. Inovio Pharmaceuticals Inc’s shares saw a change of 12.02% in year-to-date performance and have moved 13.89% in past 5-day. Inovio Pharmaceuticals Inc (NASDAQ:INO) showed a performance of 19.19% in past 30-days. Number of shares sold short was 6.46 million shares which calculate 10.33 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 20 to the stock, which implies a rise of 89.75% to its current value. Analysts have been projecting 8 as a low price target for the stock while placing it at a high target of 40. It follows that stock’s current price would drop -290.24% in reaching the projected high whereas dropping to the targeted low would mean a loss of -290.24% for stock’s current value.
Inovio Pharmaceuticals Inc (INO) estimates and forecasts
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 22.92% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 48.40% while estimates for its earnings growth in next 5 years are of 39.09%.
Inovio Pharmaceuticals Inc (NASDAQ:INO)’s Major holders
Insiders are in possession of 0.69% of company’s total shares while institution are holding 37.10 percent of that, with stock having share float percentage of 37.36%. Investors also watch the number of corporate investors in a company very closely, which is 37.10% institutions for Inovio Pharmaceuticals Inc that are currently holding shares of the company. DEEP TRACK CAPITAL, LP is the top institutional holder at INO for having 2.07 million shares of worth $16.7 million. And as of 2024-06-30, it was holding 7.5988 of the company’s outstanding shares.
The second largest institutional holder is BLACKROCK INC., which was holding about 1.71 million shares on 2024-06-30. The number of shares represents firm’s hold over 6.2741 of outstanding shares, having a total worth of $13.79 million.
On the other hand, iShares Trust-iShares Russell 2000 ETF and VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund are the top two Mutual Funds which own company’s shares. As of Mar 31, 2025 , the former fund manager was holding 896.84 shares of worth $1.84 million or 2.45% of the total outstanding shares. The later fund manager was in possession of 818.82 shares on Dec 31, 2024 , making its stake of worth around $1.68 million in the company or a holder of 2.23% of company’s stock.
